---
title: CatSci vs PharmaBlock
slug_a: catsci
slug_b: pharmablock
site: cdmo
review_signal_gate: closed
canonical_path: /compare/catsci/pharmablock
---

# CatSci vs PharmaBlock

Side-by-side profile data from each company listing on this directory.

## CatSci

- Profile: [/companies/catsci](/companies/catsci)

CatSci — UK-based partner for small molecule and complex synthetic medicines, offering route selection, process development, GMP drug substance manufacture and analytical services across four European and UK sites.

Services: 10. Modalities: 3. Indications: 0. Locations: 0. Certifications: 0. The strongest documented coverage currently appears in services (10).

### Services

- Medicinal Chemistry
- Analytical Method Development & Validation
- Small Molecule Development & Manufacturing
- API Synthesis & Manufacturing
- Solid-State Chemistry & Polymorph Screening
- Oligonucleotide Manufacturing
- Peptide Manufacturing
- Process Development
- Technology Transfer
- CMC Analytical Development

### Modalities

- Small Molecule
- Oligonucleotide
- Peptide

### Development capabilities

- Analytical method development
- Solid-state characterization

### Manufacturing capabilities

- Drug Substance (DS)

## PharmaBlock

- Profile: [/companies/pharmablock](/companies/pharmablock)

PharmaBlock — Leading provider of innovative chemistry products and services for pharmaceutical R&D and commercial manufacturing, with expertise in process development, GMP manufacturing, and low-carbon chemistry solutions.

Services: 10. Modalities: 4. Indications: 0. Locations: 9. Certifications: 0. The strongest documented coverage currently appears in services (10).

### Services

- Small Molecule Development & Manufacturing
- API Synthesis & Manufacturing
- Flow Chemistry & Continuous Manufacturing
- Solid-State Chemistry & Polymorph Screening
- Oral Solid Dosage Manufacturing
- Process Development
- Formulation Development
- Technology Transfer
- CMC Analytical Development
- CMC Regulatory Submission Support

### Modalities

- Small Molecule
- Antibody-Drug Conjugate (ADC)
- Oligonucleotide
- Peptide

### Development capabilities

- Analytical method development
- Formulation development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Oral Solid Dose (OSD)
- Flow Chemistry
- Hydrogenation
- Cryogenic (−80 °C)